Tax withheld4

Health In Tech, Inc.

Total Value

$30.0K

Filing Date

Sep 16, 2026

1 transactions

Trade Summary

On Sep 15, 2026, Qian LinLin, Chief Executive Officer, Director, 10% Owner, reported $30.0K of Health In Tech, Inc. (HIT) across 1 transactions. The filing covers Class A Common Stock and reflects balanced net activity of $0. Reported prices ranged from $0.89. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Qian LinLin
Role: Chief Executive Officer, Director, 10% Owner
Location: STUART, FL

Filing Details

Filing Date: Sep 16, 2026
Transaction Date: Sep 15, 2026
Accession Number: 0001213900-26-100592
Form Type: 4

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Sep 15, 2026	Class A Common Stock	33,725	$0.89	Tax Withholding	$30.0K

Want live alerts when Qian LinLin trades again?

Download Insider Trades to track HIT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.
(F2)Includes 887,062 restricted shares of Class A Common Stock and 8,077,605 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Qian LinLin

(Last)

(First)

(Middle)

701 S. COLORADO AVE, SUITE 1

(Street)

STUART

34994

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	09/15/2026		F		33,725⁽¹⁾	D	$0.89	8,964,667⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

2. Includes 887,062 restricted shares of Class A Common Stock and 8,077,605 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

	/s/ Lori Babcock, as attorney-in-fact for LinLin Qian	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001213900-26-100592.

Health In Tech, Inc.

Trade Summary

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when Qian LinLin trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4